Nigeria Study Shows 22% Drop in Child Malaria Cases

Nigeria just moved one giant step closer to protecting its youngest citizens from one of the world's deadliest diseases.

A major study completed in Osun state shows that Perennial Malaria Chemoprevention (PMC) reduced confirmed malaria cases in children under two by 22 percent between 2023 and 2025. Even better, overall health facility visits for sick kids dropped by 19 percent.

The findings give Nigeria the scientific proof it needs to roll out this life-saving intervention nationwide. Government leaders and health experts gathered in Abuja in August 2026 to review results that could reshape how the country fights malaria.

PMC works by giving young children a monthly dose of sulfadoxine-pyrimethamine, a safe and affordable malaria medication. Within 28 days of taking the medicine, children had more than 50 percent protection against malaria infection.

The study confirmed something even more important: PMC is safe for repeated use in young children, with no serious side effects reported. Parents can feel confident knowing the treatment protects without harming their kids.

Here's what makes this especially promising: the medication works through Nigeria's existing healthcare system. Clinics can deliver PMC alongside routine vaccinations, so no expensive new programs are needed.

When researchers combined PMC with insecticide-treated bed nets, protection soared even higher. Two simple tools working together could save countless young lives.

The Ripple Effect

Mathematical models predict that scaling up PMC across southern Nigeria between 2026 and 2030 could prevent tens of thousands of malaria episodes in children aged 2 to 18 months. That translates to fewer sick children, fewer overwhelmed clinics, and more kids reaching their second birthday healthy and thriving.

The economic case is just as strong. Cost analyses showed PMC is affordable to deliver at scale, making it realistic for a country working to protect millions of children with limited resources.

"This is an important milestone that reflects the country's continued commitment to evidence-based innovation in the fight against malaria," said Dr. Olusola Oresanya, Senior Technical Advisor at Malaria Consortium, which led the study.

Health Minister Dr. Iziaq Adekunle Salako called the findings "a significant step in our collective pursuit of innovative and data-driven solutions to eliminate malaria in Nigeria." His words reflect the optimism shared by everyone at the meeting.

The next phase begins in November, expanding PMC across all of Osun state while documenting what works best for future rollouts. Researchers will track how to make implementation smooth and effective in different community settings.

This isn't just about one study or one state. It's about giving Nigeria a proven tool to protect its most vulnerable population during their most dangerous years.